Opening New Lines of Attack against Cardiovascular Disease: Developers of cardiovascular drugs hope to disrupt newly identified molecular mechanisms by deploying highly specific small-molecule drugs and gene therapies
Genetic engineering & biotechnology news, 2022-03, Vol.42 (3), p.62-65ISSN: 1935-472X ;EISSN: 1937-8661 ;DOI: 10.1089/gen.42.03.19
Full text available
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||